ITLN1 and Insulin resistance: Additionally, OSA severity is associated with increased insulin resistance [26] and poor glucose control [30], and concentrations of omentin are reduced in patients with obesity, polycystic ovary syndrome, and type 2 diabetes, all of which are associated with insulin resistance [16, 17, 31–33].